Clinical Investigator
Similar Posts
Tri-Union Seafoods Identifies Additional Quantities of Recalled Genova® Tuna at Limited Retailers Due to Inadvertent Distribution of Previously Recalled Product
El Segundo, CA, January 16, 2026 – Tri-Union Seafoods is cautioning consumers that a third-party distributor inadvertently released quarantined product that was associated to a February 2025 recall. The initial voluntary recall was conducted following notification from our supplier that the “easy opSiluetaYa Recalls Tejocote Product Because of Possible Health Risk
SiluetaYa is recalling its tejocote root because FDA analysis has determined that the products appear to be Thevetia peruviana, or yellow oleander. All parts of the yellow oleander plant are known to contain cardiac glycosides, which are highly toxic to humans and animals. Ingestion of yellow oleandSteven H. Reynolds, DO. Long Beach, CA. EIR issued 11/23/2020
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/23/2020
Short Title (70 char) Steven H. Reynolds, DO. Long Beach, CA. EIR issued 11/23/2020
FEI Number 3017483836
Firm Name Steven H. Reynolds, DO
Record Type EIR
State CA
Establishment Type Clinical InvestigFDA approves daratumumab and hyaluronidase-fihj with bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma
On January 27, 2026, the Food and Drug Administration approved daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for adults with newly diagnosed multiple myeloma who are ineligible for autologous stem celGlam Derma – 11/03/2025
Unapproved New Drugs/Misbranded/BotoxAdvisory Letters
Advisory Letters